Dover, DE, Oct. 08, 2025 (GLOBE NEWSWIRE) -- AlphaTON Capital Corp (Nasdaq: ATON) ("AlphaTON" or the "Company"), alongside its wholly owned oncology subsidiary Tarus Therapeutics, LLC (dba Cyncado ...
Editor's Note: This story has been updated with additional quotes from Pear Therapeutics. The poster child of digital therapeutics-pharma collaborations is soon to be no more, as Novartis division ...
When the FDA approves a drug, passing that regulatory bar of safety and efficacy puts it on the path toward likely reimbursement by government and commercial payers. The same has not been true for ...
CMS needs to come around and accept these digital solutions as a standard of care. That would be a milestone.” A rising tide Since establishing the Digital Therapeutics Alliance, Martucci said that he ...
Dover, DE, Oct. 08, 2025 (GLOBE NEWSWIRE) -- AlphaTON Capital (ATON) Corp (Nasdaq: ATON) ("AlphaTON" or the "Company"), alongside its wholly owned oncology subsidiary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback